Prevalence of Alzheimer's Pathologic Endophenotypes in Asymptomatic and Mildly Impaired First-Degree Relatives

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Lampert, Erika J ^a   Roy Choudhury, Kingshuk ^a   Hostage, Christopher A ^a   Petrella, Jeffrey R ^a   Doraiswamy, P Murali ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENDOPHENOTYPE; FAMILY HISTORY; FEMALE; FIRST DEGREE RELATIVE; GENOTYPE; HERITABILITY; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; APOLIPOPROTEIN E4; ASYMPTOMATIC DISEASES; BIOLOGICAL MARKERS; ENDOPHENOTYPES; FAMILY; HIPPOCAMPUS; HUMANS; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; ORGAN SIZE; PREVALENCE; ROC CURVE; TAU PROTEINS;

EID: 84876278726     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060747     Document Type: Article

References (28)

1. Mayeux R, Stern Y, (2012) Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med 2: a006320.
2. Tanzi RE (2012) The genetics of Alzheimer disease. Cold Spring Harb Perspect Med 2(10).
3. Cupples L, Farrer L, Sadovnick A, Relkin N, Whitehouse P, et al. (2004) Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study. Genetics in Medicine 6: 192-196.
4. Silverman J, Li G, Zaccario C, Smith J, Mohs R, et al. (1994) Patterns of Risk in First-Degree Relatives of Patients With Alzheimer's Disease. Arch Gen Psychiatry 51(7): 577-586.
5. Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, et al. (2012) Dominantly Inherited Alzheimer Network. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 367(9): 795-804.
6. Fleisher AS, Chen K, Liu X, Ayutyanont N, Roontiva A, et al. (2013) Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease. Neurobiol Aging (1): 1-12.
7. Kim S, Swaminathan S, Shen L, Risacher SL, Nho K, et al. (2011) Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort. Neurology 76(1): 69-79.
8. Potkin SG, Guffanti G, Lakatos A, Turner JA, Kruggel F, et al. (2009) Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. PLoS One 4(8): e6501.
9. Schuff N, Woerner N, Boreta L, Kornfield T, Shaw LM,et al. (2009) MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Brain 132(Pt 4): 1067-77. Epub Feb 27.
10. Biffi A, Anderson CD, Desikan RS, Sabuncu M, Cortellini L, et al. (2010) Genetic variation and neuroimaging measures in Alzheimer disease. Arch Neurol 67(6): 677-85.
11. Honea RA, Vidoni ED, Swerdlow RH, Burns JM, (2012) Maternal family history is associated with Alzheimer's disease biomarkers. Journal of Alzheimer's Disease 31(3): 659-668.
12. Xiong C, Roe C, Buckles V, Fagan A, Holtzman D, et al. (2011) Role of Family History for Alzheimer Biomarker Abnormalities in the Adult Children Study. Arch Neurol 68(10): 1313-1319.
13. Honea RA, Swerlow RH, Vidoni ED, Burns JM, (2011) Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease. Neurology 76(9): 822-9.
14. Mosconi L, Mistur R, Switalski R, Brys M, Glodzik L, et al. (2009) Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease. Neurology 72(6): 513-20.
15. Mosconi L, Brys M, Switalski R, Mistur R, Glodzik L, et al. (2007) Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism. Proc Natl Acad Sci USA 104: 19067-19072.
16. Honea RA, Swerdlow RH, Vidoni ED, Goodwin J, Burns JM, (2010) Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease. Neurology 74(2): 113-20.
17. Mosconi L, Rinne JO, Tsui WH, Murray J, Li Y, (2013) Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents. Neurobiol Aging 34(1): 22-34.
18. Andrawis JP, Hwang KS, Green AE, Kotlerman J, Elashoff D, et al. (2012) Effects of ApoE4 and maternal history of dementia on hippocampal atrophy. Neurobiol Aging 33(5): 856-66.
19. Weiner MW, Aisen PS, Jack CR Jr, Jagust WJ, Trojanowski JQ, et al. (2010) Alzheimer's Disease Neuroimaging Initiative. Alzheimer's disease neuroimaging initiative: progress report and future plans. Alzheimer's Dement 6: 202-11.
20. ADNI procedures manual. Available: http://adni-info.org/Scientists/ProceduresManuals.aspx. Accessed: 2013 March 10.
21. Alzheimer's Disease Neuroimaging Initiative- Biospecimens Protocols. Available: http://adni.loni.ucla.edu/research/protocols/biospecimens-protocols/. Accessed: 2010 Jan.
22. Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, et al. (2009) Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Annals of Neurology 65(4): 403-13.
23. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, et al. (2011) Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimer's Dement 7(3): 280-92.
24. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, et al. (2010) Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 9: 119-28.
25. Han X, Jovich J, Salat D, van der Kouwe A, Quinn B, et al. (2006) Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer. Neuroimage 32(1): 180-194.
26. Okonkwo OC, Xu G, Dowling NM, Bendlin BB, Larue A, et al. (2012) Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults. Neurology 78(22): 1769-76.
27. Castellano JM, Kim J, Stewart FR, Jiang H, DeMattos RB, et al. (2011) Human apoE isoforms differentially regulate brain amyloid-β peptide clearance. Sci Transl Med 3(89): 89ra57.
28. Lewczuk P, Kamrowski-Kruck H, Peters O, Heuser I, Jessen F, et al. (2010) Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study. Mol Psychiatry 15(2): 138-45.